By putting everything into context by describing the BBB structure, emphasizing how the barrier alters in age and disease, and the current drugs explored to slow the negative outcomes of age and disease through acting directly on the BBB, the goal is to exploit the easily accessible and manipulable microbiota as a potential target to modulate the BBB
Our board-certified plastic surgeon, Dr
Okada S, Yokoyama M, Toko H, Tateno K, Moriya J, Shimizu I, et al
Its proprietary design achieves one-to-one equivalence to traditional injectable dosing
Its model is structurally different from Amazon's in one fundamental way: it is designed from the ground up as a direct-to-patient telehealth service, without the in-person primary care infrastructure that both enables and constrains Amazon's program